Showing results (121-130 of 176) with videos related to

Sort By:
Pageof 18
Journal of Clinical Pharmacology|February 24, 2006
Evaluation of the absolute oral bioavailability and bioequivalence of erlotinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in a randomized, crossover study in healthy subjectsPaul Frohna, Jianfeng Lu, Steve Eppler, et al.
Kidney Medicine|April 17, 2026
How Far Is a Kidney Willing to Go? Kidney Transplant Outcomes Based on Distance Donor Kidney Travels to Transplant CentersNakul Datta, Ahad Qureshi, Mahsa Ebadyrad, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Primary leiomyosarcoma of the vagina. A case report and literature reviewG. Ciaravino, D. S. Kapp, A. M. Vela, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2016
A survey of new oncology drug approvals in the USA from 2010 to 2015: a focus on optimal dose and related postmarketing activitiesDan Lu, Tong Lu, Mark Stroh, et al.
AJNR. American Journal of Neuroradiology|January 27, 2018
Local Glioma Cells Are Associated with Vascular DysregulationS G Bowden, B J A Gill, Z K Englander, et al.
Kidney Medicine|July 1, 2024
A2/A2B Deceased Donor Kidney Transplantation Using A2 Titers Improves Access to Kidney Transplantation: A Single-Center StudyErik L Lum, Afshin Pirzadeh, Nakul Datta, et al.
Pharmaceutical Research|April 21, 2018
A Pharmacometric Analysis of Patient-Reported Outcomes in Breast Cancer Patients Through Item Response TheoryEmilie Schindler, Lena E Friberg, Bertram L Lum, et al.
The Journal of Biological Chemistry|May 1, 1999
Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survivalL Lum, B R Wong, R Josien, et al.
Therapeutic Delivery|July 24, 2012
Antibody delivery of drugs and radionuclides: factors influencing clinical pharmacologySaileta Prabhu, C Andrew Boswell, Douglas Leipold, et al.
Cancer|December 1, 1993
Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerationsB L Lum, G A Fisher, N A Brophy, et al.
Pageof 18